[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Impact Factor 2022: 1.4
Cite Score 2022: 2.1
SJR 2022: 0.347
SNIP 2022: 0.545
..
Publication Charge
►Publication Fee
..
In Press
 In Press Articles
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 12, Issue 4 (Autumn 2021) ::
Caspian J Intern Med 2021, 12(4): 593-599 Back to browse issues page
Anticholinergic drug use in Older People: A Population- Based Study in Iran
Kimia Raei , Atena Rahimi , Seyed Reza Hosseini , Ali Akbar Moghadamnia , Ali Bijani
Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran Department of Pharmacology and Toxicology, Babol University of Medical Sciences, Babol, Iran , atena.rahimi@yahoo.com
Abstract:   (2429 Views)
Background: Elderly people are in need of several drugs due to physiological changes and multiple chronic diseases. Studies have shown that anticholinergic drugs can cause cognitive impairment, reduced physical activity, and increased mortality in elderly population. Paying attention to the anticholinergic medication use in older adults can prevent the occurrence of adverse events and increase the quality of health care. This study was conducted to quantify exposure to anticholinergic medicines in older people in Amirkola.
Methods: This study is a part of the comprehensive cohort project that was being conducted from 2011 on the case patients of 60 years and above that referred to the Amirkola Health Center. A total of 1532 individuals were included, of whom 54.9% were men. The drug information was obtained by observing the patient’s prescription and self-report questionnaires and collected data were analyzed by SPSS software. Exposure to anticholinergic medications was measured using the drug burden index-anticholinergic (DBI-Ach) and the anticholinergic drug scale (ADS).
Results: Among the 1532 elderly people with an average age of 69.21 years, 29% had DBI>0 and 36.3% had ADS>0. Also, there was a significant correlation between DBI and ADS (R=0.758). In addition, there is a significant relationship between sex variable with DBI and ADS (P=0.0001). So, women in comparison with men had higher values of DBI and ADS.
Conclusion: The findings of this study indicate that anticholinergic exposure is relatively high especially in older women, which posed special precautions to avoid inappropriate prescribing in the elderly.
Keywords: Anticholinergic Drug Scale, Drug Burden Index, Elderly, Pharmacoepidemiology
Full-Text [PDF 211 kb]   (631 Downloads)    
Type of Study: Original Article | Subject: pharmacology
Received: 2020/07/11 | Accepted: 2020/09/20 | Published: 2021/09/19
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Raei K, Rahimi A, Hosseini S R, Moghadamnia A A, Bijani A. Anticholinergic drug use in Older People: A Population- Based Study in Iran. Caspian J Intern Med 2021; 12 (4) :593-599
URL: http://caspjim.com/article-1-2416-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 12, Issue 4 (Autumn 2021) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.07 seconds with 40 queries by YEKTAWEB 4645